Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Haemonetics to Present at Morgan Stanley's Global Healthcare Conference

Haemonetics Corporation
Posted on: 31 Aug 16

PR Newswire

BRAINTREE, Mass., Aug. 29, 2017

BRAINTREE, Mass., Aug. 29, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley's Global Healthcare Conference in New York on Monday, September 11, 2017 at 4:50pm Eastern time.

The public may access Mr. Simon's presentation live via webcast at:

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at         

Gerry Gould, VP-Investor Relations
(781) 356-9402

View original content with multimedia:

SOURCE Haemonetics Corporation

PR Newswire

Last updated on: 29/08/2017

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.